首页> 外国专利> METHOD FOR DEFINING EARLY PERIOD CRITERIA FOR DETECTING HYPERCOAGULATION SINGS IN TREATING ACUTE LEUCOSIS PATIENTS

METHOD FOR DEFINING EARLY PERIOD CRITERIA FOR DETECTING HYPERCOAGULATION SINGS IN TREATING ACUTE LEUCOSIS PATIENTS

机译:确定早期标准治疗急性白细胞增多症患者的超凝信号的方法

摘要

FIELD: medicine. SUBSTANCE: method involves determining soluble fibrin monomer complexes, D-dimers in blood and fibrinogen, prothrombin index, ethanol test fibrinogen-fibrin degradation products, plasminogen values, Hagemann-dependent euglobulin lysis time and blood platelets number. Fibrinogen level being 4,21±0,2 g/l, prothrombin index being 91,9±1,3% as high, soluble fibrin monomer complexes in orthophenantrolin one being 188,0±13,9 mcg/l and ethanol test fibrinogenfibrin degradation products level being equal to 1-2 conditional units, D-dimers being higher than 500 mg/ml, plasminogen being available in the amount of 123,0±8,9%, Hagemann- dependent euglobulin lysis time being equal to 27±4,2 min and blood platelets number in blood being equal to 128±19,7•109/l, pre-DIC stage is to be diagnosed. EFFECT: high accuracy of diagnosis. 3 tbl
机译:领域:医学。实质:该方法涉及确定可溶性纤维蛋白单体复合物,血液和纤维蛋白原中的D-二聚体,凝血酶原指数,乙醇测试纤维蛋白原-纤维蛋白降解产物,纤溶酶原值,Hagemann依赖的球蛋白裂解时间和血小板数。纤维蛋白原水平为4,21≥0.2g / l,凝血酶原指数为91,9≥1.3%,原酚酞中的高可溶性纤维蛋白单体复合物为188,0 plusmn; 13.9 mcg / l和乙醇测试的纤维蛋白原纤维蛋白降解产物水平等于1-2个条件单位,D-二聚体高于500 mg / ml,纤溶酶原的可用量为123,0加%; 8.9%,哈格曼依赖性球蛋白的裂解时间等于27加倍。 4,2 min,血液中血小板数等于128±19,7• 10 9 / l,诊断为DIC前期。效果:诊断准确性高。 3汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号